| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 29 May 2026 | 18 May 2026 |
| Audited Results & Quarterly Results Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the audited financial results (standalone) of the Company for the quarter and year ended March 31, 2026. | ||
| Board Meeting | 15 Jan 2026 | 3 Jan 2026 |
| Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/01/2026 ,inter alia, to consider and approve the unaudited financial results (standalone) of the Company for the quarter ended on December 31, 2025 Please find enclosed herewith the Outcome of the Board Meeting dated 15/01/2026 for your reference. (As per BSE Announcement dated on: 15.01.2026) | ||
| Board Meeting | 8 Dec 2025 | 8 Dec 2025 |
| Please Find enclosed herewith the Outcome of the Board Meeting dated 08/12/2025 for your reference. | ||
| Board Meeting | 15 Oct 2025 | 7 Oct 2025 |
| Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/10/2025 inter alia to consider and approve The unaudited financial results (standalone) of the Company for the quarter and half year ended 30th September 2025. Please find enclosed herewith Outcome of Board Meeting Pursuant to regulation 30 of Sebi (LODR)Regulation ,2015 held on today i.e. 15th October 2025 (As per BSE Announcement dated on: 15.10.2025) | ||
| Board Meeting | 7 Aug 2025 | 29 Jul 2025 |
| Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 inter alia to consider and approve the unaudited financial results (standalone) of the Company for the quarter ended on June 30 2025. 1. Considered and approved the Un-audited financial results of the company for the quarter ended 30th June 2025. 2. Appointment of M/s. SBR & Co. LLP, Company Secretaries (LLP No. AAO-9057) as the Secretarial Auditors of the Company for Financial year 25-30. 3. Considered and approved the appointment of Mr. Navjyoti Kumar Jha as Internal Auditor of the company for the F.Y. 2025-26. 4. Re-appointment of Mr. Yogesh Agrawal as Chairman & Managing Director of the Company for the period of five (5) years with effect from 07.09.2025. Considered and approve the unaudited financial results for the quarter ended June 30, 2025 along with limited review report. Considered and approved the appointment of Mr. Navjyoti Kumar Jha as internal auditor of the company for the FY 2025-26. (As per BSE Announcement Dated on 07.08.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
